In a prospective observational study of 57 COVID-19 patients admitted into intensive care, Luther et al. assessed urinary albumin, NGAL, KIM-1, and plasma TIMP-2 at admission: the majority (89%) of patients developed AKI. The gene discussed is TIMP2; the disease is COVID-19.